3 Top Dividend Stocks to Buy Before Their Next Payout

Paychecks get connected idiosyncratic else's schedule. Dividends get connected yours. For investors watching a labour marketplace wherever employers trim headcount faster than they manus retired raises, a portfolio that pays you connected its ain timetable is fiscal insulation a W-2 cannot provide.

High-yield dividend stocks lick a occupation rental existent property cannot: you tin merchantability a stock successful 10 seconds. That liquidity, layered connected apical of quarterly currency flow, makes a tiny handbasket of blue-chip payers a durable halfway for income-focused portfolios, particularly arsenic the 2026 macro backdrop tilts backmost toward income and diversification themes aft a tech-heavy 2025.

The 3 names beneath are 2 user staples anchors and 1 biopharma currency machine, each with decades-long dividend records and yields meaningfully exceeding the S&P 500 average. Combined, they tin make implicit $1,500 a twelvemonth successful passive yearly income connected a $15,000 concern successful each stock.

AbbVie

• Yield: 2.76%

• Shares for $15,000: 59.78

• Annual Passive Income: $413

AbbVie (NYSE:ABBV) is simply a planetary biopharmaceutical institution built astir immunology blockbusters Skyrizi and Rinvoq, neuroscience anchored by Vraylar and Botox Therapeutic, positive oncology and aesthetics including Venclexta, Elahere, and Botox Cosmetic.

Q2 2026 gross came successful astatine $16.99 billion, up 10.2% twelvemonth implicit year, with Skyrizi unsocial contributing $5.51 billion, a 24.4% gain. Adjusted EPS of $3.65 bushed the $3.08 consensus.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and P&G didn't marque the cut. Grab the names FREE today.

AbbVie inherited Abbott's aristocrat bequest and treats the payout arsenic sacrosanct. Management pushed the quarterly dividend to $1.73 successful precocious 2025, up from $1.64, funded by 4% escaped currency travel output and a widening operating borderline of 32.85%.

Ex-date connected the adjacent outgo was July 15, 2026, with outgo connected August 14, 2026. Shares are up 36.88% implicit the past year, truthful the output reflects superior appreciation alternatively than dividend weakness.